CD73-IN-10

• UNSPSC Description:

  CD73-IN-10 is a potent inhibitor of CD73. CD73 can catalyze the production of adenosine from extracellular 5'-phosphate adenosine (5'-AMP), and adenosine can induce immunosuppressive effects and promote tumor proliferation and/or metastasis. CD73-IN-10 be used for preparing a medicament for tumor-related diseases (extracted from patent WO2022068929A1, compound 4)[1].

• Target Antigen:

  CD73

• Type:

  Reference compound

• Related Pathways:

  Immunology/Inflammation

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Cancer; Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/cd73-in-10.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CN1N=CC2=C1N=C(C=C2[C@@H]3[C@@H](C(F)F)C3)C4=CNC(NC4=O)=O

• Molecular Weight:

  333.29

• References & Citations:

  [1]Xuejun Zhang, et al. Pyrimidinedione compound and use thereof. Patent WO2022068929A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2766565-91-5